Growth rate of clinically diagnosed superficial basal cell carcinoma and changes in dermoscopic features over time by Sykes, Adrian Jonathan et al.
                          Sykes, A. J., Wlodek, C., Trickey, A., Clayton, G. L., & Oakley, A.
(2020). Growth rate of clinically diagnosed superficial basal cell
carcinoma and changes in dermoscopic features over time.
Australasian Journal of Dermatology.
https://doi.org/10.1111/ajd.13352
Peer reviewed version
Link to published version (if available):
10.1111/ajd.13352
Link to publication record in Explore Bristol Research
PDF-document
This is the author accepted manuscript (AAM). The final published version (version of record) is available online
via Wiley at https://onlinelibrary.wiley.com/doi/abs/10.1111/ajd.13352 . Please refer to any applicable terms of
use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the










Background/Objectives: Basal cell carcinoma (BCC) is the most commonly occurring skin cancer. BCCs have 
been found to generally grow slowly. Data is limited on how the dermoscopic characteristics of BCCs evolve. 
We set out to determine the growth rate of superficial BCCs (sBCC) and assess the change in dermoscopic 
features over time. 
 
Methods: A retrospective review was performed of clinically diagnosed sBCC. Images, demographic and 
dermoscopic data were collected by a melanographer. Mixed effects linear regression models were used to 
investigate sBCC growth and associations between size and dermoscopic/demographic variables. We tested 
differences in trends over time in dermoscopic features using non-parametric trend tests. 
 
Results: 100 individual sBCC were evaluated in 70 patients (mean age 62; 59% male), 69% had Fitzpatrick 
skin phototype 1 or 2, and 81% had some degree of actinic damage. sBCC were present on the back in 58% 
and 22% of men and women, respectively. The median surface area was 41.9 mm2 with a growth rate of 
0.81mm2/month. Males had larger sBCC than females. There was no association between sBCC size and 
Fitzpatrick skin phototype, history of skin cancer, or family history of melanoma. There is some evidence 
larger sBCC gain shiny white structures (p=0.053) over time. 
 
Conclusions: sBCC grow at a rate unlikely to adversely affect patient outcomes associated with long wait 
times. Our data suggests that dermoscopy can aid in appropriate treatment selection for sBCC. 
 
 






New Zealand has one of the highest rates of skin cancer in the world1. Basal cell carcinoma (BCC) represents 
the majority of these cancers with one study finding 73% of non-melanoma (keratinocytic) skin cancers in 
New Zealand were BCCs2. In New Zealand, there is no mandatory reporting of BCC to the National Cancer 
Registry but a histological examination study in 2008 found an annual BCC incidence rate of 1,177 per 
100,000 population in Auckland, the largest city in New Zealand1,2. The actual rate of BCCs is likely to be 
higher given that superficial BCCs (sBCC) are often diagnosed clinically and treated without histological 
confirmation. A significant burden is placed on the health system to manage these BCCs, with a UK study 
finding the treatment of choice is surgical excision in 58% of cases3,4. Delays can arise in accessing 
appropriate treatment within a suitable timeframe. There have been few studies examining the growth rate 
of BCCs to observe if delays in treatment result in poor outcomes for patients. Several studies have 
investigated the growth rate in patients awaiting surgical excision of BCCs. It has generally been accepted 
that BCCs grow slowly with two prospective studies finding a median increase in major diameter of nodular 
BCC of 0.5mm over a mean time of 10 weeks5,6. However, one study found an increase in major diameter 
size of 10mm over 19 weeks whilst another found periocular BCCs increased their surface area by a mean 
rate of 11.2mm2 every 30 days7,8. We were unable to find any reports of growth rates of BCCs over periods 
longer than 12 months and none specifically looking at the growth rate of sBCC.  
 
Dermoscopy is a validated method to confirm the diagnosis of BCC9-14. The International Dermoscopy Society 
have established BCC dermoscopic diagnostic criteria on Dermoscopedia9. Many studies have described the 
correlation between BCC dermoscopic features and histological findings10-14. We were unable to identify any 
studies looking at the change in dermoscopic features in a population of BCCs over time.  
 
The aim of this study was to determine the growth rate of sBCC and the change in dermoscopic features over 
time through a retrospective review of clinical and dermoscopic.  We hypothesise that sBCC in non-
cosmetically sensitive areas exhibit a rate of growth unlikely to impact on patient outcome due to long wait 
times and acquire dermoscopic features in keeping with growth and invasion. We also wished to investigate 
whether demographic factors affect sBCC growth rates. 
 
 




The study was a retrospective review of clinical and dermoscopic images taken by an experienced 
melanographer in patients attending a skin mapping service between August 2005 and August 2018. 
Consecutive patients were included as potential participants where a clinical diagnosis of sBCC was made by 
an experienced teledermatologist using the pattern recognition method for flat non-pigmented lesions15. 
The diagnostic report is sent to the patient to action with their usual treating physician/general practitioner. 
To be included in the study, the sBCC must have been present on at least two separate occasions with no 
evidence of treatment between visits. Exclusion criteria were clinically non-superficial BCCs when first 
imaged, poor-quality images, and large tumours in which the lesion was not fully contained within a single 
dermoscopic view. High-quality images of each lesion containing macroscopic, polarised, and non-polarised 
dermoscopic views were included. Additional data included lesion location, demographics (age at each visit 
and sex) and skin cancer risk factor data (history of non-melanoma/melanoma skin cancer, family history of 
skin cancer, Fitzpatrick skin phototype, actinic damage (based on dermatologist designed rating scale: 0 – 
none, 1 – pigmentary change, 2 - <50% sun exposed sites affected with actinic keratoses, 3 - >50% sun 
exposed sites affected with actinic keratoses), as assessed by the experienced melanographer, history of 
immunosuppression, and occupational sun exposure) for each patient. The body location for each lesion was 
recorded and the long axis (mm), short axis (mm), and surface area (mm2) were measured using proprietary 
software (MoleMapView). Measurements were performed by the same researcher (AS) three times and a 
mean value was recorded. Each imaged BCC was assessed for dermoscopic features of BCCs as defined on 
 
 
Dermoscopedia by the International Dermoscopy Society (Appendix table 1) using descriptive terminology 




Mixed effects linear regression models were used to account for repeated observations per person. Three 
continuous dependent variables were investigated: (1) long axis measurements (mm2); (2) short axis 
measurements (mm2); (3) surface area measurements (mm2). The relationships between these three 
dependent variables were investigated with time of follow-up in months and (a) various dermoscopic 
variables (Appendix 1) and; (b) various demographic and skin cancer risk factor variables (Appendix table 1). 
Complete case analysis was performed. 
 
Associations of size with dermoscopic variables and time 
 
The relationships between the three dependent variables and the dermoscopic variables were first examined 
separately for each dermoscopic variable without further adjustment. Secondly, the relationship of each 
dependent variable with each independent variable was examined adjusting only for the time of follow-up in 
months. Thirdly, for each dependent variable, the independent variables with an association with p≤0.1 were 
entered into a final adjusted model. The dermoscopic variables considered were shiny white structures, lines 
radial connected to a common base, lines radial converging, clods brown/blue concentric, clods blue large 
clustered, clods blue small, short fine superficial telangiectasia, microerosions, and ulceration. 
 
Associations of size with demographics 
 
Univariable relationships between the demographic and cancer risk factor variables and the three 
dependent variables were assessed. The demographic and cancer risk factor variables with p≤0.1 were then 
entered into an adjusted model for each of the three dependent variables to investigate whether 
demographic variables affect carcinoma growth. The demographic variables considered were gender, skin 
type, family history of melanoma, personal history of non-melanoma skin cancer, personal history of 
melanoma, actinic damage, presence of sunburn, sunbed use, history of immunosuppression, and 
occupational exposure. 
 
Dermoscopic features over time 
 
To investigate how dermoscopic features change over time, we tabulated the features for sBCC at baseline, 1 
year, and 2 years, classifying the sBCC by size (< or ≥41.9mm2 surface area). We tested the differences in 




This study was deemed, by the Health and Disability Ethics Committees as being out of scope and therefore 







In total, 100 individual sBCC were assessed in 70 patients with a mean age of 62 years (interquartile range 
52–70). The median number of treatment visits for each BCC was 2 (range 2–7). Males represented 59% of 
the population, 69% of participants had Fitzpatrick skin phototype 1 or 2, and 81% had at least some degree 
of actinic damage (severe in 14%). A personal history of melanoma was reported in 17% and a family history 
in 25%, with 56% having a history of non-melanoma skin cancer (Table 1). Table 2 shows the body location 
 
 
for the studied sBCC in males and females. Most of the BCCs in males were located on their backs (58%), 
whilst this was the case for only 22% of females. The majority (54%) of the observed BCCs in females were 
on their limbs, while only 17% of BCCs in males were located on the limbs. Histological examination was 
available for 16 of the 100 lesions (16%) and sBCC was confirmed in 14 out of the 16 lesions (88%). One 
lesion was histologically consistent with morphoeic BCC, whilst the other was micronodular invasive BCC.  
 
The median long axis measurement of the sBCC on presentation (baseline) was 8.7mm with a median short 
axis measurement of 6.2mm. The median surface area was 41.9mm2. Table 1 also shows the prevalence of 
dermoscopy features displayed within the BCCs on initial presentation. Lines white perpendicular was the 
most common feature recorded (46%), with branched blood vessels present in 32% of participants. 
 
Associations of size with dermoscopic variables and time 
 
Table 3 shows multivariable associations between sBCC size and dermoscopic variables for longitudinal axis, 
short axis, and surface area. Appendix tables 2a-c gives further results of these analyses. In univariable 
analyses, we found a longitudinal axis growth coefficient of 0.07 mm/month (95% confidence interval [95% 
CI]: 0.06, 0.09), or 0.84 mm/year, a short axis growth rate of 0.06 mm/month (95% CI: 0.05, 0.07), 0.72 
mm/year, and a surface area growth rate of 0.96 mm2/month (95% CI: 0.078, 1.14), or 11.5 mm2/year. In 
multivariable analyses we found growth rates of 0.07 mm/month (95% CI: 0.05, 0.08), or 0.84 mm/year, for 
the longitudinal axis, 0.04 mm/month (95% CI: 0.03, 0.05), or 0.48 mm/year, for the short axis, and 0.81 
mm2/month (95% CI: 0.64, 0.99), or 9.7mm2/year, for the surface area. 
 
For the multivariable analysis with long axis measurement as the outcome, we found that shiny white 
structures and clods brown/blue concentric were positively associated with long axis size, whilst presence of 
short fine superficial telangiectasia was negatively associated with long axis size. Presence of shiny white 
structures, clods brown/blue concentric, clods blue clustered, clods blue small, microerosion were all 
positively associated with short axis measurement size. The multivariable analysis showed positive 
associations between surface area measurement and presence of shiny white structures, clods brown/blue 
concentric, clods blue small, and ulceration. 
 
Associations of size with demographics 
 
Males had larger BCCs than females in the multivariable analyses of surface area and short axis 
measurements, with a weaker association in the analysis of long axis measurements (Table 4 and appendix 
tables 3a-c). There was no association between size of sBCC and Fitzpatrick skin phototype, history of skin 
cancer (melanoma and non-melanoma), or family history of melanoma for any of the measurements. There 
was some evidence that sBCC in patients with severe actinic damage had a larger short axis measurement. 
The growth rate coefficients for each of the measurements were unchanged when additionally adjusting for 
demographic variables.  
 
Dermoscopic features over time 
 
Table 5 demonstrates that over time there is some evidence that larger sBCC (≥41.9cm2) gain shiny white 






Our study into the growth of clinically diagnosed sBCC supports previous research showing that BCCs are 
slow growing5,6,16. The majority of sBCC occur in non-cosmetically sensitive sites (trunk and limbs) and 
therefore a change in surface area of less than 1mm2 per month should not have significant consequences to 




We found that surface area measurements of sBCC in males tended to be larger than in females. This might 
be explained by differences in the location of the sBCC. For males, most of the recorded sBCC were on their 
backs, whilst in females most of the sBCC were on their limbs. The causal mechanism underpinning this 
difference in sBCC distribution is unknown. It is unclear if differences in the growth rates of sBCC at different 
anatomical locations may account for males having larger sBCC at presentation than females. Similar sex 
differences have been found when studying the distribution of melanoma, with men more likely to have a 
primary melanoma on the back and women more likely to have one on the lower limbs19,20. It has been 
hypothesised that this difference in location is due to the style of clothing with a bare torso being more 
common in men while women are more likely to have bare limbs19. 
 
We found the most common features to be ‘shiny white structures’, ‘short fine telangiectasia’ (arborising or 
serpentine vessels), and microerosions. Larger sBCC size (>41.9cm2) was associated with having ‘shiny white 
structures’, ‘clods brown/blue concentric’, and ‘clods blue small’. Scalvenzi et al. described the dermoscopic 
features and their prevalence in sBCC in 2008 and found that shiny white areas, short fine telangiectasia, and 
erosions were associated with sBCC21.  
 
The correlation between dermoscopic features and underlying histology has been studied previously11,12,14. 
‘Clods blue clustered’ and ‘clods blue small’ are linked to melanin-containing cells located within the reticular 
dermis, while ‘lines radial connected to a common base at edge’ (maple leaf-like area), ‘lines radial 
converging’ (spoke-wheel structure), and ‘clods brown/blue concentric’ are linked with melanin-containing 
cells within the papillary dermis1. sBCC, by definition, are confined to, or are contiguous with, the epidermis 
and should not invade the reticular dermis22. Our study shows that superficial BCCs gain signs of deeper 
dermal involvement as they enlarge with minimal presence of these features in the initial lesions.  
 
Dermoscopic examination of sBCC can inform treatment decisions23. Options for sBCC are wider than for the 
other histological subtypes and include topical and surgical treatment. Topical treatment for sBCC has 
previously been reported to have a high failure rate, possibly due to clinical under-diagnosis of the depth of 
the tumour24. We therefore suggest that surgical excision be considered if dermoscopic signs of dermal 
involvement are present. If topical treatment is used, close follow-up is essential to ensure resolution, with 
consideration of biopsy or excision of the lesion should it persist or acquire features suggesting dermal 
invasion. 
 
Several patients were noted to have lesions persisting for a few years without evidence of treatment — the 
longest in the cohort was observed for 7 years (Figure 1). The reasons for delay in treatment were not 
reported in these cases and are unknown. Van Egmond et al. found that patients have a preference for 
dialogue with their diagnosing physician25. Clear explanation of the diagnosis and treatment options is 
essential for patients who want to participate in a shared decision-making model. The skin mapping service 
in this study uses store-and-forward teledermatology for diagnosis and treatment recommendations. There 
is no discourse between the diagnosing dermatologist and the patient. Lesion location may contribute to 
delay in treatment. Most lesions occurred on the back, a difficult area to self-monitor.  
 
Strengths and limitations 
 
To our knowledge, this study is the first to track the growth of sBCC using multiple types of measurement. 
Limitations to our study include demographic data, which was largely self-reported and is therefore subject 
to recall bias; we were unable to confirm the history provided by the patient. Histological confirmation of 
sBCC was only available for 16% of the lesions but did confirm the initial clinical diagnosis of sBCC in 88% of 
these. Whilst this number is low, it does reflect that the diagnosis of sBCC is largely clinical and treatment is 
commonly non-surgical. The high histological confirmation of the clinical diagnosis supports the algorithm 
used in this study. Dermoscopy has previously been shown to have a sensitivity and specificity of 81.9% and 
81.8% respectively26. It is possible that lesions which clinically appeared to be sBCC were another histological 
 
 
subtype confounding our results, as the growth and dermoscopic features of each histological subtype of 




Our study supports the belief that sBCC is slow growing at a rate of less than 1mm2 per month. Therefore, 
delays in treatment of sBCC, due to long wait times, are unlikely to affect patient outcome in non-
cosmetically sensitive sites. This is reassuring news for patients. We have found that dermoscopic signs of 
dermal involvement develop as larger sBCC enlarge. This knowledge should aid in planning the appropriate 
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Figure 1: Annual dermoscopic images of single lesion located on the back in one patient followed over seven 
years showing persistence in lesion despite exhibiting clinical (not shown) and dermoscopic features of sBCC 






Table 1: Baseline patient characteristics and measurements for each BCC 
 
 Median (Interquartile range) 
Long axis measurement at baseline (mm) 8.7 (6.5, 11.1) 
Short axis measurement at baseline (mm) 6.2 (4.7, 8.4) 
Surface area measurement at baseline (mm2) 41.9 (22.7, 73.6) 
Age (years) at baseline photo 62.0 (52.0, 70.5) 
 N = 100 (%) 
Fitzpatrick skin phototype:  
  1 8 (8%) 
  2 61 (61%) 
  3 30 (30%) 
  4 1 (1%) 
  
Male 59 (59%) 
  
Personal history of melanoma 17 (17%) 
Personal history of non-melanoma skin cancer 56 (56%) 
Family history of melanoma 25 (25%) 
  
Degree of actinic damage  
  Non-significant 19 (19%) 
  Some (pigmentary change) 48 (48%) 
  Moderate 19 (19%) 
  Severe 14 (14%) 
Dermoscopic variables N = 100 (%) 
Shiny white structures 50 (50%) 
Lines radial connected to a common base 15 (15%) 
Lines radial converging 7 (7%) 
Clods brown/blue concentric 14 (14%) 
Clods blue clustered 9 (9%) 
Clods blue small 17 (17%) 
Short fine superficial telangiectasia 43 (43%) 
Micro erosion 26 (26%) 





Table 2: Location of BCC by gender 
 Location Male [N = 59] (%) Female [N = 41] (%) 
Arm 2 (3%) 9 (22%) 
Leg 8 (14%) 13 (32%) 
Chest 8 (14%) 3 (7%) 
Back 34 (58%) 9 (22%) 
Head 5 (8%)  4 (10%) 






Table 3: Univariable and multivariable associations of dermoscopic variables with the long axis, short axis, 
and surface area measurements*. Full tables of adjusted coefficients are given in the appendix. 
Variable Univariable 
coefficient (95% CI) 
P-value Multivariable 
coefficient (95% CI) 
P-value 
Endpoint: Long axis measurement (mm)     
Time (in months) 0.07 [0.06, 0.09] <0.001 0.07 [0.05, 0.08] <0.001 
Shiny white structures 0.65 [0.11, 1.19] 0.018 0.55 [0.04, 1.06] 0.036 
Clods brown/blue concentric 0.98 [0.26, 1.69] 0.008 0.97 [0.27, 1.66] 0.007 
Short fine superficial telangiectasia -0.96 [-1.50, -0.42] 0.001 -0.90 [-1.44, -0.35] 0.001 
Constant term   8.92 [8.22, 9.62]  
Endpoint: Short axis measurement (mm)     
Time (in months) 0.06 [0.05, 0.07] <0.001 0.04 [0.03, 0.05] <0.001 
Shiny white structures 0.59 [0.17, 1.01] 0.006 0.74 [0.34, 1.14] <0.001 
Clods brown/blue concentric 0.77 [0.21, 1.34] 0.007 0.85 [0.31, 1.40] 0.002 
Clods blue clustered 0.49 [-0.09, 1.08] 0.098 0.56 [-0.01, 1.13] 0.056 
Clods blue small 0.47 [-0.01, 0.94] 0.053 0.48 [0.02, 0.94] 0.042 
Microerosion 0.48 [0.11, 0.85] 0.011 0.55 [0.19, 0.90] 0.002 
Constant term   5.88 [5.31, 6.46]  
Endpoint: Surface area measurement (mm2)     
Time (in months) 0.96 [0.78, 1.14] <0.001 0.81 [0.64, 0.99] <0.001 
Shiny white structures 7.11 [1.74, 12.49] 0.009 7.26 [2.10, 12.44] 0.006 
Clods brown/blue concentric 8.35 [1.18, 15.52] 0.022 8.07 [1.03, 15.11] 0.025 
Clods blue small 6.14 [0.23, 12.05] 0.042 6.76 [0.85, 12.66] 0.025 
Ulceration 11.15 [0.52, 21.77] 0.040 10.39 [-0.06, 20.85] 0.051 
Constant term   43.82 [36.60, 51.04]  
CI: Confidence interval 






Table 4: Univariable and multivariable associations of demographic variables with the long axis, short axis, 
and surface area measurements*. Full tables of adjusted coefficients are given in the appendix. 




Endpoint: Long axis measurement (mm)   
Time (in months) 0.07 (0.06, 0.09) 0.07 (0.06, 0.09) 
Male 1.22 (-0.11, 2.55) 1.27 (-0.04, 2.59) 
Endpoint: Short axis measurement (mm)   
Time (in months) 0.06 (0.05, 0.07) 0.06 (0.05, 0.07) 
Male 1.34 (0.13, 2.55) 1.52 (0.33, 2.71) 
Actinic damage   
   No significant Comparator Comparator 
   Some 0.71 (-0.80, 2.22) 1.00 (-0.48, 2.48) 
   Moderate 0.85 (-0.99, 2.69) 1.00 (-0.79, 2.79) 
   Severe 1.80 (-0.16, 3.75) 1.97 (0.07, 3.87) 
Endpoint: Surface area measurement (mm2)   
Time (in months) 0.96 (0.78, 1.14) 0.96 (0.78, 1.13) 
Male 18.36 (3.17, 33.55) 18.72 (3.43, 34.02) 
CI: Confidence interval 






Table 5: Change in dermoscopic features over time for small (surface area < 41.9 mm2) compared to large 
(surface area ≥ 41.9 mm2) superficial basal cell carcinomas 
  Baseline (N = 100) Year 1 (N = 100) Year 2 (N = 72)  
Dermoscopic variables  Small = 49, Large = 51 Small = 49, Large = 51 Small = 35, Large = 37 P-value* 
Shiny white structures 
Small 20 (41%) 21 (43%) 14 (40%) 0.963 
Large 30 (59%) 35 (69%) 29 (78%) 0.053 
Lines radial connected to a 
common base 
Small 8 (16%) 7 (14%) 5 (14%) 0.784 
Large 7 (14%) 7 (14%) 5 (14%) 0.979 
Lines radial converging 
Small 4 (8%) 5 (10%) 6 (17%) 0.215 
Large 3 (6%) 5 (10%) 6 (16%) 0.117 
Clods brown/blue 
concentric 
Small 6 (12%) 6 (12%) 9 (26%) 0.117 
Large 8 (16%) 8 (16%) 7 (19%) 0.704 
Clods blue clustered 
Small 4 (8%) 5 (10%) 5 (14%) 0.377 
Large 5 (10%) 5 (10%) 3 (8%) 0.800 
Clods blue small 
Small 10 (20%) 14 (29%) 12 (34%) 0.153 
Large 7 (14%) 6 (12%) 7 (19%) 0.539 
Short fine superficial 
telangiectasia 
Small 22 (45%) 23 (47%) 14 (40%) 0.693 
Large 21 (41%) 26 (51%) 19 (51%) 0.319 
Micro erosion 
Small 8 (16%) 12 (24%) 8 (23%) 0.428 
Large 18 (35%) 17 (33%) 16 (43%) 0.486 
Ulceration 
Small 0 (0%) 0 (0%) 0 (0%) NA 
Large 5 (10%) 6 (12%) 3 (8%) 0.834 
*Non-parametric trend test for differences across years in the percentage of patients (either with small or 



















Appendix Table 1: Comparison of descriptive and metaphorical terms for BCC dermoscopy features 
 
Descriptive Terminology Metaphorical Terminology 
Shiny white structures Shiny white streaks/crystalline 
Lines radial connected to a common base Leaf-like areas 
Lines radial converging Spoke-wheel area/structure 
Clods brown/blue concentric Concentric globules 
Clods blue large clustered Blue-grey ovoid nests 
Clods blue small Blue globules 






































Appendix Table 2a: Univariable and multivariable coefficients for long axis measurement with dermoscopic 
variables and time. 
 





















































Time (in months) 0.072 (0.058, 0.086) <0.001 NA NA 0.070 (0.055, 0.085) <0.001 
       
Dermoscopic variables:       
Shiny white structures 1.34 (0.78, 1.91) <0.001 0.65 (0.11, 1.19) 0.018 0.55 (0.37, 1.06) 0.036 
Lines radial connected to 
common base at edge 
0.36 (-0.42, 1.13) 0.365 0.24 (-0.46, 0.93) 0.506   
Lines radial converging 0.91 (0.15, 1.67) 0.019 0.43 (-0.26, 1.12) 0.222   
Clods brown/blue concentric 1.08 (0.29, 1.88) 0.008 0.98 (0.26, 1.69) 0.008 0.97 (0.27, 1.66) 0.007 
Clods blue clustered 0.51 (-0.29, 1.32) 0.212 0.37 (-0.37, 1.12) 0.326   
Clods blue small 0.34 (-0.33, 1.01) 0.321 0.22 (-0.38, 0.83) 0.468   
Short finest -0.76 (-1.35, -0.17) 0.011 -0.96 (-1.50, -0.42) 0.001 -0.90 (-1.44, -0.35) 0.001 
Micro-erosion 0.74 (0.22, 1.26) 0.005 0.39 (-0.08, 0.85) 0.108   
Ulceration 0.87 (-0.34, 2.08) 0.160 0.43 (-0.67, 1.52) 0.447   
Constant     8.92 (8.22, 9.62)  
 
 
Appendix table 2b: Univariable and multivariable coefficients for short axis measurement with dermoscopic 
variables and time.  
 
 


















































coefficient (95% CI) 
p-value 
Time (in months) 0.061 (0.050, 0.071) <0.001 NA NA 0.042 (0.033, 0.052) <0.001 
       
Dermoscopic variables:       
Shiny white structures 1.21 (0.75, 1.67) <0.001 0.59 (0.17, 1.01) 0.006 0.74 (0.34, 1.14) <0.001 
Lines radial connected to 
common base at edge 
0.32 (-0.31, 0.95) 0.327 0.33 (-0.22, 0.87) 0.237   
Lines radial converging 0.75 (0.13, 1.36) 0.018 0.41 (-0.14, 0.95) 0.142   
Clods brown/blue concentric 0.72 (0.08, 1.37) 0.028 0.77 (0.21, 1.34) 0.007 0.85 (0.31, 1.40) 0.002 
Clods blue clustered 0.55 (-0.10, 1.20) 0.095 0.49 (-0.09, 1.08) 0.098 0.56 (-0.01, 1.13) 0.056 
Clods blue small 0.63 (0.10, 1.16) 0.020 0.47 (-0.01, 0.94) 0.053 0.48 (0.02, 0.94) 0.042 
Short finest 0.12 (-0.38, 0.62) 0.641 -0.09 (-0.54, 0.36) 0.686   
Micro-erosion 0.82 (0.40, 1.23) <0.001 0.48 (0.11, 0.85) 0.011 0.55 (0.19, 0.90) 0.002 
Ulceration 0.30 (-0.69, 1.28) 0.553 0.07 (-0.80, 0.94) 0.873   




Appendix table 2c: Univariable and multivariable coefficients for surface area measurement with 
dermoscopic variables and time. 
 

















































coefficient (95% CI) 
p-value 
Time (in months) 0.961 (0.785, 1.137) <0.001 NA NA 0.815 (0.636, 0.993) <0.001 
       
Dermoscopic variables:       
Shiny white structures 13.83 (8.02, 19.65) <0.001 7.11 (1.74, 12.49) 0.009 7.27 (2.10, 12.44) 0.006 
Lines radial connected to 
common base at edge 
1.56 (-6.15, 9.28) 0.691 1.22 (-5.67, 8.12) 0.728   
Lines radial converging 8.33 (0.69, 15.98) 0.033 4.28 (-2.60, 11.15) 0.223   
Clods brown/blue concentric 8.77 (0.94, 16.61) 0.028 8.35 (1,18, 15.52) 0.022 8.07 (1.03, 15.11) 0.025 
Clods blue clustered 3.62 (-4.14, 11.37) 0.361 1.89 (-5.30, 9.08) 0.606   
Clods blue small 8.61 (2.12, 15.09) 0.009 6.14 (0.23, 12.05) 0.042 6.76 (0.85, 12.66) 0.025 
Short finest -2.60 (-8.61, 3.40) 0.395 -4.52 (-10.04, 0.99) 0.108   
Micro-erosion 66.41 (1.14, 11.68) 0.017 3.22 (-1.45, 7.89) 0.177   
Ulceration 15.32 (3.71, 26.92) 0.010 11.15 (0.52, 21.77) 0.040 10.39 (-0.06, 20.84) 0.051 
Constant     43.81 (36.60, 51.04)  
 
 
Appendix table 3a: Univariable and multivariable coefficients for long axis measurement with demographic 





























































 Univariable (95% CI) p-value Multivariable (95% CI) p-value 
Time (months) 0.072 (0.058, 0.086) <0.001 0.072 (0.058, 0.086) <0.001 
     
Age at first photo 0.01 (-0.04, 0.07) 0.674   
     
Skin type     
1 Comparator NA   
2 0.95 (-1.28, 3.18) 0.404   
3 -0.21 (-2.57, 2.15) 0.861   
4 2.50 (-3.95, 8.94) 0.448   
     
Male 1.22 (-0.11, 2.55) 0.072 1.27 (-0.04, 2.59) 0.057 
     
Hx melanoma -0.57 (-2.21, 1.08) 0.482   
     
Hx NMSC -0.41 (-1.65, 0.83) 0.514   
     
FHx melanoma 0.47 (-0.95, 1.91) 0.513   
     
Actinic damage     
  No significant Comparator    
  Some 0.14 (-1.52, 1.781) 0.864   
  Moderate 0.79 (-1.19, 2.77) 0.435   
  Severe 0.63 (-1.51, 2.77) 0.564   
     
History of sunburn 1.33 (-0.27, 2.92) 0.102   
     
Sunbed use 1.98 (-4.25, 8.20) 0.534   
     
Immunosuppression -2.13 (-8.15, 3.88) 0.487   
     
Occupational exposure 0.82 (-1.36, 3.00) 0.461   
     
Constant   8.19 (7.16, 9.22)  
 
 
Appendix table 3b: Univariable and multivariable coefficients for short axis measurement with demographic 





























































 Univariable (95% CI) p-value Multivariable (95% CI) p-value 
Time (months) 0.061 (0.050, 0.071) <0.001 0.060 (0.050, 0.071) <0.001 
     
Age at first photo 0.02 (-0.03, 0.07) 0.383   
     
Skin type     
1 Comparator    
2 0.53 (-1.63, 2.68) 0.633   
3 -0.37 (-2.66, 1.92) 0.753   
4 -0.35 (-6.06, 5.37) 0.906   
     
Male 1.34 (0.13, 2.55) 0.030 1.52 (0.33, 2.71) 0.012 
     
Hx melanoma -0.78 (-2.32, 0.77) 0.323   
     
Hx NMSC -0.75 (-1.96, 0.47) 0.227   
     
FHx melanoma 0.37 (-0.98, 1.71) 0.594   
     
Actinic damage     
  No significant Comparator  Comparator  
  Some 0.71 (-0.80, 2.22) 0.433 1.00 (-0.48, 2.48) 0.187 
  Moderate 0.85 (-0.99, 2.69) 0.367 1.00 (-0.79, 2.79) 0.274 
  Severe 1.80 (-0.16, 3.75) 0.072 1.97 (0.07, 3.87) 0.042 
     
History of sunburn 0.86 (-0.61, 2.32) 0.253   
     
Sunbed use -0.55 (-6.00, 4.89) 0.842   
     
Immunosuppression -1.63 (-6.91, 3.65) 0.546   
     
Occupational exposure 0.17 (-1.86, 2.21) 0.867   
     
Constant   4.83 (3.38, 6.29)  
 
 
Appendix table 3c: Univariable and multivariable coefficients for surface area measurement with 






































Hx: History of; FHX: Family history of; NMSC: Non-melanoma skin cancer; CI: Confidence interval 
 
 Univariable (95% CI) p-value Multivariable (95% CI) p-value 
Time (months) 0.960 (0.784, 1.135) <0.001 0.959 (0.784, 1.134) <0.001 
     
Age at first photo 0.30 (-0.34, 0.94) 0.354   
     
Skin type     
1 Comparator    
2 7.05 (-19.98, 34.09) 0.609   
3 -3.03 (-31.75, 25.69) 0.836   
4 5.52 (-66.46, 77.49) 0.881   
     
Male 18.36 (3.17, 33.55) 0.018 18.72 (3.43, 34.02) 0.016 
     
Hx melanoma -10.25 (-29.60, 9.10) 0.299   
     
Hx NMSC -6.50 (-21.78, 8.78) 0.404   
     
FHx melanoma 4.59 (-12.26, 21.44) 0.593   
     
Actinic damage     
  No significant Comparator    
  Some 2.92 (-16.34, 22.18) 0.766   
  Moderate 6.22 (-17.13, 29.57) 0.602   
  Severe 14.24 (-10.59, 39.06) 0.261   
     
History of sunburn 11.67 (-6.75, 30.09) 0.214   
     
Sunbed use 2.15 (-66.40, 70.70) 0.951   
     
Immunosuppression -15.82 (-82.67, 51.03) 0.643   
     
Occupational exposure 1.98 (-23.58, 27.54) 0.879   
     
Constant   39.51 (27.56, 51.47)  
